Birchview Capital »

Travere Therapeutics shares owned by Birchview Capital

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Birchview Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $733k 82k 8.94
2023-06-30 $614k 40k 15.36
2023-03-31 $675k 30k 22.50